Skip to main content
TipRanks
Go Ultimate75% OFF

Hanall Biopharma Co., Ltd. (009420) Balance Sheet

Hanall Biopharma Co., Ltd. Balance Sheet

Hanall Biopharma Co., Ltd.'s total assets for Q3 2026 were ₩217.27B, a decrease of 9.67% from the previous quarter. KR:009420 total liabilities were ₩63.22B for the fiscal quarter, a 19.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
₩ 225.22B₩ 212.88B₩ 239.75B₩ 213.45B₩ 198.48B
₩ 63.54B₩ 44.53B₩ 53.53B₩ 45.19B₩ 34.99B
₩ 161.68B₩ 168.35B₩ 186.22B₩ 168.26B₩ 163.49B

Currency in KRW

Hanall Biopharma Co., Ltd. Liabilities to Assets

0100B200B300B16 %24 %32 %40 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets